Nexgel 

$0.012500
22
-$0.00-20.88% Friday 16:40
+$0.00+0%Friday 22:51After hours

Statistics

Day High
0.0159
Day Low
0.0125
52W High
0.0159
52W Low
0.0125
Volume
3,980
Avg. Volume
-
Mkt Cap
121,845.79
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.4
-0.29
-0.18
-0.07
Expected EPS
-0.24
Actual EPS
N/A

Financials

-26.27%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
11.42MRevenue
-3MNet Income

Analyst Ratings

0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXGLW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its subsidiary companies, produces a variety of healthcare products that compete directly with Nexgel's wound care and gel products.
3M
MMM
Mkt Cap89.91B
3M operates in the healthcare segment offering medical products that include wound care solutions, competing with Nexgel's offerings.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation offers a range of medical technologies, including wound management and surgical products that can compete with Nexgel's advanced healing solutions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc provides medical technologies, services, and solutions, including wound care and patient monitoring systems that compete with Nexgel's product line.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with Nexgel in the wound care market.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including wound care solutions that compete with Nexgel.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a portfolio of healthcare products, including advanced recovery and wound care products, directly competing with Nexgel's offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; and wound care and related products that compete with Nexgel.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, indirectly competing with Nexgel's wound healing solutions.

About

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
Show more...
CEO
Adam R. Levy
Employees
19
Country
United States
ISIN
US65344E1156

Listings

0 Comments

Share your thoughts

FAQ

What is Nexgel stock price today?
The current price of NXGLW is $0.01 USD — it has decreased by -20.88% in the past 24 hours. Watch Nexgel stock price performance more closely on the chart.
What is Nexgel stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Nexgel stocks are traded under the ticker NXGLW.
What is Nexgel market cap?
Today Nexgel has the market capitalization of 121,845.79
When is the next Nexgel earnings date?
Nexgel is going to release the next earnings report on November 17, 2026.
What were Nexgel earnings last quarter?
NXGLW earnings for the last quarter are -0.4 USD per share, whereas the estimation was -0.12 USD resulting in a -233.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nexgel revenue for the last year?
Nexgel revenue for the last year amounts to 11.42M USD.
What is Nexgel net income for the last year?
NXGLW net income for the last year is -3M USD.
How many employees does Nexgel have?
As of September 05, 2026, the company has 19 employees.
In which sector is Nexgel located?
Nexgel operates in the Health & Wellness sector.
When did Nexgel complete a stock split?
Nexgel has not had any recent stock splits.
Where is Nexgel headquartered?
Nexgel is headquartered in LANGHORNE, United States.